Search fresh public links, source activity, and ready-to-use post angles for Glp-1 Medications.
Fresh curated links around GLP-1 Medications are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
MONDAY, July 20, 2026 — Popular medications used to treat type 2 diabetes and obesity, known as GLP-1 receptor agonists, have been linked to a small increase in the risk of a rare...
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
Eli Lilly Debuts Advertisement Selling GLP-1s to Medicare Enrollees
Eli Lilly Debuts Advertisement Selling GLP-1s to Medicare Enrollees
What the evidence says about their growing list of established and emerging uses The post GLP-1 medications beyond weight loss: how far could their benefits extend? appeared first...
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects.
PARK CITY, Utah — When used for weight loss, previously published literature has shown GLP-1s may lead to bone resorption and muscle loss. However, a presenter here said the additi...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
New research suggests GLP-1 medications may be associated with a lower likelihood of developing breast cancer. GLP-1 medications have transformed the treatment of obesity and type...
New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of medications. Millions of people are now using GLP-1 receptor agonis...
Governor Mike Braun announced that Indiana will allow eligible residents to access select GLP-1 medications through Medicaid via a new federal demonstration program.
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
Amylin analogs are in clinical trials to address metabolic diseases on their own as well as to enhance the effects of GLP-1 drugs. The post Amylin analogs in the clinic: a deep d...
Maker of the popular medications Ozempic and Wegovy filed a lawsuit against Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.